- Home
- ONCY vs SOL Comparison
ONCY vs SOL Comparison
Compare ONCY & SOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- SOL
- Stock Information
- Founded
- ONCY 1998
- SOL 2005
- Country
- ONCY Canada
- SOL United States
- Employees
- ONCY N/A
- SOL N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- SOL Semiconductors
- Sector
- ONCY Health Care
- SOL Technology
- Exchange
- ONCY Nasdaq
- SOL Nasdaq
- Market Cap
- ONCY 89.7M
- SOL 98.5M
- IPO Year
- ONCY 1999
- SOL 2008
- Fundamental
- Price
- ONCY $1.36
- SOL $1.89
- Analyst Decision
- ONCY Strong Buy
- SOL Strong Buy
- Analyst Count
- ONCY 5
- SOL 2
- Target Price
- ONCY $5.00
- SOL $4.50
- AVG Volume (30 Days)
- ONCY 1.3M
- SOL 119.1K
- Earning Date
- ONCY 11-11-2025
- SOL 11-13-2025
- Dividend Yield
- ONCY N/A
- SOL N/A
- EPS Growth
- ONCY N/A
- SOL N/A
- EPS
- ONCY N/A
- SOL N/A
- Revenue
- ONCY N/A
- SOL $68,445,000.00
- Revenue This Year
- ONCY N/A
- SOL N/A
- Revenue Next Year
- ONCY N/A
- SOL $45.37
- P/E Ratio
- ONCY N/A
- SOL N/A
- Revenue Growth
- ONCY N/A
- SOL N/A
- 52 Week Low
- ONCY $0.33
- SOL $1.04
- 52 Week High
- ONCY $1.53
- SOL $3.00
- Technical
- Relative Strength Index (RSI)
- ONCY 64.50
- SOL 54.27
- Support Level
- ONCY $1.20
- SOL $1.87
- Resistance Level
- ONCY $1.44
- SOL $1.91
- Average True Range (ATR)
- ONCY 0.11
- SOL 0.03
- MACD
- ONCY 0.01
- SOL 0.00
- Stochastic Oscillator
- ONCY 81.40
- SOL 81.00
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has globalised Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. Majority of revenue is From Electricity Generation. The company operates in China, USA, Germany, UK, Spain, France, Poland, Italy, Hungary, Luxembourg. Majority of revenue is from Italy.